Access to anti-retroviral drugs, female in Costa Rica
Costa Rica: Access to anti-retroviral drugs, female was 65.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Costa Rica, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Costa Rica stood at 65.0%. That is the highest value across all 25 years on record.
The figure is up 80.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Costa Rica peaked at 65.0% in 2023 and was at its lowest, 13.0%, in 2000.
That places Costa Rica 91st out of 141 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Costa Rica, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 13.0% | — |
| 2001 | 17.0% | +30.8% |
| 2002 | 21.0% | +23.5% |
| 2003 | 24.0% | +14.3% |
| 2004 | 26.0% | +8.3% |
| 2005 | 29.0% | +11.5% |
| 2006 | 31.0% | +6.9% |
| 2007 | 33.0% | +6.5% |
| 2008 | 35.0% | +6.1% |
| 2009 | 36.0% | +2.9% |
| 2010 | 38.0% | +5.6% |
| 2011 | 39.0% | +2.6% |
| 2012 | 38.0% | -2.6% |
| 2013 | 41.0% | +7.9% |
| 2014 | 36.0% | -12.2% |
| 2015 | 44.0% | +22.2% |
| 2016 | 47.0% | +6.8% |
| 2017 | 49.0% | +4.3% |
| 2018 | 52.0% | +6.1% |
| 2019 | 46.0% | -11.5% |
| 2020 | 53.0% | +15.2% |
| 2021 | 58.0% | +9.4% |
| 2022 | 60.0% | +3.4% |
| 2023 | 65.0% | +8.3% |
| 2024 | 65.0% | +0.0% |
Costa Rica compared with similar countries
- Costa Rica's 65.0% is below the median for high income countries, which is 82.0%, 79% of the median. (39 countries reporting)
- Costa Rica's 65.0% is below the median for Latin America & Caribbean, which is 68.0%, 96% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.5% | 13.0% | 36.0% | 10 |
| 2010s | 43.0% | 36.0% | 52.0% | 10 |
| 2020s | 60.2% | 53.0% | 65.0% | 5 |
Countries ranked near Costa Rica
More gender data for Costa Rica
- Child population (UN estimates and projections) 838.24 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.49 % change on previous year (2030)
- Population 4,413 (2030)
- Working-age population (UN estimates and projections) 4,413 (2030)
- Population (UN estimates and projections), annual growth rate 0.8911 % change on previous year (2030)
- Age population, age 00, female, interpolated 24,787 (2025)
- Age population, age 00, male, interpolated 25,901 (2025)
- Age population, age 01, female, interpolated 25,098 (2025)
- Age population, age 01, male, interpolated 26,214 (2025)
- Age population, age 02, female, interpolated 25,387 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Costa Rica?
- Access to anti-retroviral drugs, female in Costa Rica was 65.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Costa Rica?
- The highest recorded value was 65.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Costa Rica?
- The lowest recorded value was 13.0% in 2000.
- How does Costa Rica rank for access to anti-retroviral drugs, female?
- Costa Rica ranks 91st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Costa Rica?
- Over the last ten years it is up 80.6%. The long-run trend across the full record is rising.
- Where does this Costa Rica data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.